Ambalalrabhai Enterprises (NSE:AMBALALSA) Cyclically Adjusted PS Ratio: (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMBALALSA Ambalal Sarabhai Enterprises Ltd NSE:AMBALALSA
52 GF Score
Price ₹45.94
GF Value ₹41.96
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ambalalrabhai Enterprises  (NSE:AMBALALSA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio Related Terms


Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Ambalalrabhai Enterprises's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio Chart

Ambalalrabhai Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.94

Ambalalrabhai Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.47 1.29 1.12 0.94

NSE:AMBALALSA vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ambalalrabhai Enterprises's Cyclically Adjusted PS Ratio falls into.


NSE:AMBALALSA
52GF Score
Ambalal Sarabhai Enterprises Ltd NSE:AMBALALSA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambalalrabhai Enterprises Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ambalalrabhai Enterprises's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Ambalalrabhai Enterprises's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.562/164.2724*164.2724
=8.562

Current CPI (Mar. 2026) = 164.2724.

Ambalalrabhai Enterprises Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201706 3.781 107.109 5.799
201709 3.214 109.021 4.843
201712 3.896 109.404 5.850
201803 5.555 109.786 8.312
201806 4.846 111.317 7.151
201809 3.837 115.142 5.474
201812 4.800 115.142 6.848
201903 5.787 118.202 8.043
201906 4.136 120.880 5.621
201909 3.317 123.175 4.424
201912 4.119 126.235 5.360
202003 4.653 124.705 6.129
202006 3.446 127.000 4.457
202009 5.533 130.118 6.985
202012 5.927 130.889 7.439
202103 6.118 131.771 7.627
202106 5.575 134.084 6.830
202109 7.347 135.847 8.884
202112 5.666 138.161 6.737
202203 6.866 138.822 8.125
202206 5.794 142.347 6.686
202209 5.969 144.661 6.778
202212 4.706 145.763 5.304
202303 5.529 146.865 6.184
202306 4.744 150.280 5.186
202309 5.168 151.492 5.604
202312 5.482 152.924 5.889
202403 7.025 153.035 7.541
202406 5.862 155.789 6.181
202409 5.802 157.882 6.037
202412 6.494 158.323 6.738
202503 7.266 157.552 7.576
202506 5.249 159.755 5.397
202509 5.555 162.289 5.623
202512 6.792 163.281 6.833
202603 8.562 164.272 8.562

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ambalalrabhai Enterprises (NSE:AMBALALSA) Overvalued in 2026?

Based on GuruFocus' analysis, Ambalalrabhai Enterprises stock appears to be overvalued. The current stock price of ₹45.94 is trading 9.5% above its estimated GF Value™ of ₹41.96. GuruFocus considers Ambalalrabhai Enterprises to be Fairly Valued.

Key valuation signals for NSE:AMBALALSA:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹41.96 vs. price of ₹45.94 (9.5% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the NSE:AMBALALSA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambalalrabhai Enterprises Business Description

Other Exchanges 500009:India
Address Mirzapur Road, Shanti Sadan, Ahmedabad, GJ, IND, 380001
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. The operating segment of the company is Pharmaceutical Products. It serves domestic as well as International markets.
52GF Score

Get the complete analysis for NSE:AMBALALSA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹45.94
Price
₹41.96
GF Value